医薬品製造の世界市場2020-2027:市場規模、シェア、動向分析

Grand View Researchが発行した調査報告書(GV20NV006)
◆英語タイトル:Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Drug Development Type, By Formulation, By Route Of Administration, By Therapy Area, By Prescription, By Age Group, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV006
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月3日
◆ページ数:170
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、医薬品製造の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、医薬品開発種類別市場規模(社内、外注)、製剤別市場規模(錠剤、カプセル、注射剤、スプレー、懸濁液、粉末)、投与経路別市場規模(経口、局所、非経口、吸入、その他)、治療領域別市場規模(心血管疾患、疼痛、糖尿病、癌、呼吸器疾患)、処方箋別市場規模(処方薬品、OTC薬品)、年齢層別市場規模(子供・青年、大人、高齢者)、流通経路別市場規模(小売、非小売)、地域別市場規模、競争状況などの項目を掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・医薬品製造の世界市場規模:医薬品開発種類別(社内、外注)
・医薬品製造の世界市場規模:製剤別(錠剤、カプセル、注射剤、スプレー、懸濁液、粉末)
・医薬品製造の世界市場規模:投与経路別(経口、局所、非経口、吸入、その他)
・医薬品製造の世界市場規模:治療領域別(心血管疾患、疼痛、糖尿病、癌、呼吸器疾患)
・医薬品製造の世界市場規模:処方箋別(処方薬品、OTC薬品)
・医薬品製造の世界市場規模:年齢層別(子供・青年、大人、高齢者)
・医薬品製造の世界市場規模:流通経路別(小売、非小売)
・医薬品製造の世界市場規模:地域別
・競争状況
【レポートの概要】

Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 1,902.6 billion by 2027, expanding at a CAGR of 4.6%, according to a new report by Grand View Research, Inc. The pharmaceutical firms have implemented cloud technology to increase operational efficiency across R&D and manufacturing processes. This technology has led to the generation of consolidated and standardized data that reduces complexities and inefficiencies, which speeds up the process of drug development. Thus, the implementation of cloud technology and artificial intelligence is expected to drive the market.

Longer life expectancies and a rise in the geriatric population has spurred the demand for pharmaceutical products to treat several chronic disorders. These factors have also prompted many individuals to use medications to improve the quality of life and wellness, globally. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues to pharmaceutical manufacturers to accelerate their drug production.

Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize the costs incurred in making a product, overcome medicine shortages, and improve efficiencies. For instance, in August 2019, GlaxoSmithKline plc opened two continuous manufacturing facilities in Singapore with an investment of USD 95.6 million. This initiative is expected to boost the company’s drug development in minimal production timelines.

Pharmaceutical Manufacturing Market Report Highlights

• In-house drug development accounted for the largest revenue share of more than 50.0% in 2019 due to continuous efforts undertaken by the key players to expand their manufacturing capacities for therapeutics

• Tablets held the maximum revenue share in 2019 owing to wide acceptance by physicians and patients, ease of manufacturing, and easy formulation process of tablets with desired drug properties

• The advent of pre-filled syringes and auto-injectors is expected to drive the parenteral segment with the fastest growth rate during the forecast period

• Increase in awareness and growth in the demand for early cancer diagnosis has resulted in the development of oncology drugs at a large scale globally

• Over-the-Counter (OTC) medicines segment are anticipated to grow at a lucrative pace throughout the forecast period due to the continuous transition from prescription to OTC

• This shift from prescription medicines to OTC medicines has potentially benefitted the patients both financially and in terms of better health

• The children and adolescents segment is expected to grow at the fastest rate due to the presence of supportive government initiatives that encourage pediatric studies

• The Pediatric Research Equity Act and Best Practices for Children Act are among the few initiatives of the FDA that focus on the development of drugs for children

• Retail sale channels held the maximum revenue share as a large percentage of individuals use a retail pharmacy as their one-stop-shop for pharmaceutical products

• North America dominated the market in terms of revenue share as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers

• Key players operating in this market have undertaken several growth initiatives to expand production facilities

• For instance, in January 2020, Novartis stated about its decision to collaborate with NHS England to improve the manufacture of oligonucleotide cardiovascular drugs in the UK.

【レポートの目次】

Table of Contents

Chapter 1 Pharmaceutical Manufacturing Market: Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country wise market estimation using bottom up approach
1.7 Global Market: CAGR Calculation
1.8 List of Secondary Sources
1.9 List of Primary Sources
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Pharmaceutical Manufacturing Market: Executive Summary
2.1 Pharmaceutical Manufacturing Market: Market Outlook
2.2 Pharmaceutical Manufacturing Market: Market Segmentation
2.3 Pharmaceutical Manufacturing Market: Competitive Insights
2.4 Market Summary
Chapter 3 Pharmaceutical Manufacturing Market: Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping for Route of Administration, 2019
3.2 Pharmaceutical Manufacturing: Pipeline Analysis
3.3 Pharmaceutical Manufacturing: Medicine Usage and Spending
3.4 Pharmaceutical Manufacturing Market: Impact of COVID-19 Infection
3.4.1 Effects on supply chain
3.4.2 Distribution and logistics concerns
3.4.3 Pharma research into COVID-19
3.5 Pharmaceutical Manufacturing: Regulatory Framework
3.5.1 Regulatory framework in the U.S.
3.5.2 Regulatory framework in the Europe
3.5.3 Regulatory framework in China
3.5.4 Regulatory framework in India
3.5.5 Regulatory framework in Brazil
3.6 Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Rise in pharmaceutical R&D spending
3.6.1.2 Advancements in pharmaceutical manufacturing technologies
3.6.1.3 Rise in focus towards healthcare needs of emerging nations
3.6.1.4 Growth in geriatric population and incidence rate of chronic disorders
3.6.2 Market restraint analysis
3.6.2.1 Patent expiration of most profitable drugs
3.6.2.2 Pricing pressures on pharmaceutical companies
3.6.3 Market challenge analysis
3.6.3.1 Challenges pertaining pharma supply chain
3.6.3.2 Lack of skilled professionals
3.6.4 Market opportunity analysis
3.6.4.1 Increase in number of clinical trials
3.6.4.2 Investment and funding programs in pharmaceutibcal manufacturing industry
3.7 Business environment analysis
3.7.1 Pharmaceutical manufacturing market: SWOT analysis; by factor (political & legal, economic and technological)
3.7.2 Porter’s Five Forces analysis
3.8 Market Strategic Alliances
3.8.1 Agreement
3.8.2 Merger & acquisition
3.8.3 Partnership & collaboration
3.9 Market Entry Strategies
3.9.1 Entry strategies
3.9.2 Market entry strategies for small and midsized companies
Chapter 4 Pharmaceutical Manufacturing Market: Drug Development Type Business Analysis
4.1 Pharmaceutical Manufacturing Market: Drug Development Type Movement Analysis
4.2 In-house
4.2.1 Global in-house pharmaceutical manufacturing market, 2016 – 2027 (USD Billion)
4.3 Outsource
4.3.1 Global Outsource Pharmaceutical Manufacturing Market, 2016 – 2027 (USD Billion)
Chapter 5 Pharmaceutical Manufacturing Market: Formulation Business Analysis
5.1 Pharmaceutical Manufacturing Market: Formulation Movement Analysis
5.2 Tablets
5.2.1 Global pharmaceutical manufacturing market for tablets, 2016 – 2027 (USD Billion)
5.3 Capsules
5.3.1 Global pharmaceutical manufacturing market for capsules, 2016 – 2027 (usd Billion)
5.4 Injectable
5.4.1 Global pharmaceutical manufacturing market for injectable, 2016 – 2027 (USD Billion)
5.5 Sprays
5.5.1 Global pharmaceutical manufacturing market for sprays, 2016 – 2027 (USD Billion)
5.6 Suspensions
5.6.1 Global pharmaceutical manufacturing market for suspensions, 2016 – 2027 (USD Billion)
5.7 Powders
5.7.1 Global pharmaceutical manufacturing market for powders, 2016 – 2027 (USD Billion)
5.8 Other Formulations
5.8.1 Global pharmaceutical manufacturing market for other formulations, 2016 – 2027 (USD Billion)
Chapter 6 Pharmaceutical Manufacturing Market: Routes Of Administration Business Analysis
6.1 Pharmaceutical Manufacturing Market: Routes of Administration Movement Analysis
6.2 Oral
6.2.1 Global pharmaceutical manufacturing market for oral route of administration, 2016 – 2027 (USD Billion)
6.3 Topical
6.3.1 Global pharmaceutical manufacturing market for topical route of administration, 2016 – 2027 (USD Billion)
6.4 Parenteral
6.4.1 Global pharmaceutical manufacturing market for parenteral route of administration, 2016 – 2027 (USD Billion)
6.5 Inhalations
6.5.1 Global pharmaceutical manufacturing market for inhalations route of administration, 2016 – 2027 (USD Billion)
6.6 Other Routes of Administration
6.6.1 Global pharmaceutical manufacturing market for other route of administration, 2016 – 2027 (USD Billion)
Chapter 7 Pharmaceutical Manufacturing Market: Therapy Area Business Analysis
7.1 Pharmaceutical Manufacturing Market: Therapy Area Movement Analysis
7.2 Cardiovascular Diseases
7.2.1 Global pharmaceutical manufacturing market for cardiovascular diseases, 2016 – 2027 (USD Billion)
7.3 Pain
7.3.1 Global pharmaceutical manufacturing market for pain, 2016 – 2027 (USD Billion)
7.4 Diabetes
7.4.1 Global pharmaceutical manufacturing market for diabetes, 2016 – 2027 (USD Billion)
7.5 Cancer
7.5.1 Global pharmaceutical manufacturing market for cancer, 2016 – 2027 (USD Billion)
7.6 Respiratory Diseases
7.6.1 Global pharmaceutical manufacturing market for respiratory diseases, 2016 – 2027 (USD Billion)
7.7 Other Diseases
7.7.1 Global pharmaceutical manufacturing market for other diseases, 2016 – 2027 (USD Billion)
Chapter 8 Pharmaceutical Manufacturing Market: Prescription Business Analysis
8.1 Pharmaceutical Manufacturing Market: Prescription Movement Analysis
8.2 Prescription Medicines
8.2.1 Global pharmaceutical manufacturing market for prescription medicines, 2016 – 2027 (USD Billion)
8.3 Over-the-counter (OTC) Medicines
8.3.1 Global pharmaceutical manufacturing market for OTC medicines, 2016 – 2027 (USD billion)
Chapter 9 Pharmaceutical Manufacturing Market: Age GroupBusiness Analysis
9.1 Pharmaceutical Manufacturing Market: Age GroupMovement Analysis
9.2 Children & Adolescents
9.2.1 Global pharmaceutical manufacturing market for children & adolescents, 2016 – 2027 (USD Billion)
9.3 Adults
9.3.1 Global pharmaceutical manufacturing market for adults, 2016 – 2027 (USD Billion)
9.4 Geriatric
9.4.1 Global pharmaceutical manufacturing market for geriatric, 2016 – 2027 (USD Billion)
Chapter 10 Pharmaceutical Manufacturing Market: Distribution Channel Business Analysis
10.1 Pharmaceutical Manufacturing Market: Distribution Channel Movement Analysis
10.2 Retail
10.2.1 Global pharmaceutical manufacturing market for retail channels, 2016 – 2027 (USD Billion)
10.3 Non-retail
10.3.1 Global pharmaceutical manufacturing market for non-retail, 2016 – 2027 (USD Billion)
Chapter 11 Pharmaceutical Manufacturing Market: Regional Business Analysis
11.1 Pharmaceutical Manufacturing Market: Regional Movement Analysis, 2019 & 2027
11.2 North America
11.2.1 North America pharmaceutical manufacturing market estimates and forecast, 2016 – 2027 (USD Billion)
11.2.2 The U.S.
11.2.2.1 The U.S. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027(USD Billion)
11.2.2.2 The U.S. pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.2.2.3 The U.S. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.2.2.4 The U.S. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.2.2.5 The U.S. pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.2.2.6 The U.S. pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.2.2.7 The U.S. pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.2.3 Canada
11.2.3.1 Canada pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.2.3.2 Canada pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.2.3.3 Canada pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.2.3.4 Canada pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.2.3.5 Canada pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.2.3.6 Canada pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.2.3.7 Canada pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.3 Europe
11.3.1 Europe pharmaceutical manufacturing market estimates and forecast, 2016 – 2027 (USD Billion)
11.3.2 Germany
11.3.2.1 Germany pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.3.2.2 Germany pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.3.2.3 Germany pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.3.2.4Germany pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.3.2.5 Germany pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.3.2.6 Germany pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.3.2.7 Germany pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.3.3 The U.K.
11.3.3.1 The U.K. pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.3.3.2 The U.K. pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.3.3.3 The U.K. pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.3.3.4 The U.K. pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.3.3.5 The U.K. pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.3.3.6 The U.K. pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.3.3.7 The U.K. pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.3.4 France
11.3.4.1 France pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.3.4.2 France pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.3.4.3 France pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.3.4.4 France pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.3.4.5 France pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.3.4.6 France pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.3.4.7 France pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.3.5 Italy
11.3.5.1 Italy pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.3.5.2 Italy pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.3.5.3 Italy pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.3.5.4Italy pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.3.5.5 Italy pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.3.5.6 Italy pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.3.5.7 Italy pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.3.6 Spain
11.3.6.1 Spain pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.3.6.2 Spain pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.3.6.3 Spain pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.3.6.4Spain pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.3.6.5 Spain pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.3.6.6 Spain pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.3.6.7 Spain pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.4 Asia-Pacific
11.4.1 Asia Pacific pharmaceutical manufacturing market estimates and forecast, 2016 – 2027 (USD Billion)
11.4.2 Japan
11.4.2.1 Japan pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.4.2.2 Japan pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.4.2.3 Japan pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.4.2.4Japan pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.4.2.5 Japan pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.4.2.6 Japan pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.4.2.7 Japan pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.4.3 China
11.4.3.1 China pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.4.3.2China pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.4.3.3China pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.4.3.4China pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.4.3.5China pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.4.3.6China pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.4.3.7China pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.4.4 India
11.4.4.1 India pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.4.4.2India pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.4.4.3India pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.4.4.4India pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.4.4.5India pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.4.4.6India pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.4.4.7India pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.5 Latin America
11.5.1 Latin America pharmaceutical manufacturing market estimates and forecast, 2016 – 2027 (USD Billion)
11.5.2 Brazil
11.5.2.1 Brazil pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.5.2.2Brazil pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.5.2.3Brazil pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.5.2.4Brazil pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.5.2.5Brazil pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.5.2.6Brazil pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.5.2.7Brazil pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.5.3 Mexico
11.5.3.1 Mexico pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.5.3.2 Mexico pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.5.3.3 Mexico pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.5.3.4 Mexico pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.5.3.5 Mexico pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.5.3.6 Mexico pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.5.3.7 Mexico pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.6 Middle East and Africa (MEA)
11.6.1 MEA pharmaceutical manufacturing market estimates and forecast, 2016 – 2027 (USD Billion)
11.6.2 South Africa
11.6.2.1 South Africa pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.6.2.2South Africa pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.6.2.3South Africa pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.6.2.4South Africa pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.6.2.5South Africa pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.6.2.6South Africa pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.6.2.7South Africa pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by drug development type, 2016 – 2027 (USD Billion)
11.6.3.2Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by formulation, 2016 – 2027 (USD Billion)
11.6.3.3Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by route of administration, 2016 – 2027 (USD Billion)
11.6.3.4Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by therapy area, 2016 – 2027 (USD Billion)
11.6.3.5Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by prescription, 2016 – 2027 (USD Billion)
11.6.3.6Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by age group, 2016 – 2027 (USD Billion)
11.6.3.7Saudi Arabia pharmaceutical manufacturing market estimates and forecast, by distribution channel, 2016 – 2027 (USD Billion)
Chapter 12 Pharmaceutical Manufacturing Market: Competitive Landscape
12.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
12.2 Recent Developments & Impact Analysis, by Key Market Participants
12.3 Public Companies
12.3.1 Top pharmaceutical companies
12.4 Private Companies
12.4.1 List of key emerging companies
12.5 Strategy Framework
12.6 Market Participation Categorization
12.7 Company Profiles
12.7.1 AstraZeneca
12.7.1.1 Company overview
12.7.1.2 Financial performance
12.7.1.3 Product benchmarking
12.7.1.4 Strategic initiatives
12.7.2 F. Hoffmann-La Roche Ltd.
12.7.2.1 Company overview
12.7.2.2 Financial performance
12.7.2.3 Product benchmarking
12.7.2.4 Strategic initiatives
12.7.3 Merck & Co., Inc.
12.7.3.1 Company overview
12.7.3.2 Financial performance
12.7.3.3 Product benchmarking
12.7.3.4 Strategic initiatives
12.7.4 Pfizer, Inc.
12.7.4.1 Company overview
12.7.4.2 Financial performance
12.7.4.3 Product benchmarking
12.7.4.4 Strategic initiatives
12.7.5 Lonza
12.7.5.1 Company overview
12.7.5.2 Financial performance
12.7.5.3 Product benchmarking
12.7.5.4 Strategic initiatives
12.7.6 Novartis AG
12.7.6.1 Company overview
12.7.6.2 Financial performance
12.7.6.3 Product benchmarking
12.7.6.4 Strategic initiatives
12.7.7 GlaxoSmithKline plc
12.7.7.1 Company overview
12.7.7.2 Financial performance
12.7.7.3 Product benchmarking
12.7.7.4 Strategic initiatives
12.7.8 Eli Lilly And Company
12.7.8.1 Company overview
12.7.8.2 Financial performance
12.7.8.3 Product benchmarking
12.7.8.4 Strategic initiatives
12.7.9 Sanofi
12.7.9.1 Company overview
12.7.9.2 Financial performance
12.7.9.3 Product benchmarking
12.7.9.4 Strategic initiatives
12.7.10 Johnson & Johnson
12.7.10.1 Company overview
12.7.10.2 Financial performance
12.7.10.3 Product benchmarking
12.7.10.4 Strategic initiatives

List of Tables

TABLE 1 Comparison of drug delivery technologies of ten advanced pharmaceutical technologies (1980-2017)
TABLE 2 Number of active drugs by diseases in 2019
TABLE 3 Therapy wise healthcare spending in developed and pharmerging nations in 2017 (USD Billion)
TABLE 4 Top ten most common prescribed drugs in the U.S.
TABLE 5 List of secondary sources include, but are not limited to:
TABLE 6 Number of pipeline products for top pharmaceutical companies
TABLE 7 Number of pipeline products for top pharmaceutical companies
TABLE 8 Major regulatory agencies globally
TABLE 9 Major Indian regulations for pharmaceuticals
TABLE 10 List of major drug patent expirations in 2019
TABLE 11 Major entry strategies
TABLE 12 Advantages and disadvantages of different routes of administration
TABLE 13 List of top cardiovascular drugs
TABLE 14 Recent pediatric labeling information
TABLE 15 North America pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 16 North America pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 17 North America pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 18 North America pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 19 North America pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 20 North America pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 21 North America pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 22 The U.S. pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 23 The U.S. pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 24 The U.S. pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 25 The U.S. pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 26 The U.S. pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 27 The U.S. pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 28 The U.S. pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 29 Canada pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 30 Canada pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 31 Canada pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 32 Canada pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 33 Canada pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 34 Canada pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 35 Canada pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 36 Europe pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 37 Europe pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 38 Europe pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 39 Europe pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 40 Europe pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 41 Europe pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 42 Europe pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 43 Germany pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 44 Germany pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 45 Germany pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 46 Germany pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 47 Germany pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 48 Germany pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 49 Germany pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 50 The U.K. pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 51 The U.K. pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 52 The U.K. pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 53 The U.K. pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 54 The U.K. pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 55 The U.K. pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 56 The U.K. pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 57 France pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 58 France pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 59 France pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 60 France pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 61 France pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 62 France pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 63 France pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 64 Italy pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 65 Italy pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 66 Italy pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 67 Italy pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 68 Italy pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 69 Italy pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 70 Italy pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 71 Spain pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 72 Spain pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 73 Spain pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 74 Spain pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 75 Spain pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 76 Spain pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 77 Spain pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 78 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 79 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 80 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 81 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 82 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 83 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 84 Asia Pacific pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 85 Japan pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 86 Japan pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 87 Japan pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 88 Japan pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 89 Japan pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 90 Japan pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 91 Japan pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 92 China pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 93 China pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 94 China pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 95 China pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 96 China pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 97 China pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 98 China pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 99 India pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 100 India pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 101 India pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 102 India pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 103 India pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 104 India pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 105 India pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 106 Latin America pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 107 Latin America pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 108 Latin America pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 109 Latin America pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 110 Latin America pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 111 Latin America pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 112 Latin America pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 113 Brazil pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 114 Brazil pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 115 Brazil pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 116 Brazil pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 117 Brazil pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 118 Brazil pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 119 Brazil pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 120 Mexico pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 121 Mexico pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 122 Mexico pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 123 Mexico pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 124 Mexico pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 125 Mexico pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 126 Mexico pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 127 MEA pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 128 MEA pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 129 MEA pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 130 MEA pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 131 MEA pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 132 MEA pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 133 MEA pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 134 South Africa pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 135 South Africa pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 136 South Africa pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 137 South Africa pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 138 South Africa pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 139 South Africa pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 140 South Africa pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 141 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by drug development type, 2016 - 2027 (USD Billion)
TABLE 142 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by formulation, 2016 - 2027 (USD Billion)
TABLE 143 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by routes of administration, 2016 - 2027 (USD Billion)
TABLE 144 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by therapy area, 2016 - 2027 (USD Billion)
TABLE 145 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by prescription requirements, 2016 - 2027 (USD Billion)
TABLE 146 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by age group, 2016 - 2027 (USD Billion)
TABLE 147 Saudi Arabia pharmaceutical manufacturing market estimates and forecasts, by distribution channels, 2016 - 2027 (USD Billion)
TABLE 148 List of key emerging companies
TABLE 149 List of contract manufacturers

List of Figures

FIG. 1 Market research process
FIG. 2 Data triangulation techniques
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Comparison of major key players
FIG. 9 Development of active pharmaceutical ingredients (API) by type
FIG. 10 Distribution of different dosage formulations of oral and inhalation drug delivery technologies
FIG. 11 Analysis of different routes of administration of FDA-approval pharmaceutical products
FIG. 12 FDA drug approvals by route of administration from 2015 to 2018
FIG. 13 Estimated spending by therapy area in 2020 (in percentage)
FIG. 14 Prevalence rate of chronic disorders by age group
FIG. 15 Distribution of R&D companies by region 2019 and 2018
FIG. 16 Percentage of API manufacturing facilities by region, 2019
FIG. 17 Pharmaceutical manufacturing market segmentation
FIG. 18 Market snapshot (USD Billion)
FIG. 19 Penetration and growth prospect mapping for route of administration, 2019
FIG. 20 Total R&D pipeline size from 2001 to 2019
FIG. 21 Comparison of pipeline by phase for 2019 and 2018
FIG. 22 Pipeline analysis by therapy area, 2019 and 2018
FIG. 23 Medicine spending by region in 2015 and 2018 (USD Billion)
FIG. 24 Estimated medicine spending by region in 2023 for branded and OTC medicines (in percentage)
FIG. 25 New and estimated brand spending in developed markets from 2009 to 2023 (USD Billion)
FIG. 26 Specialty medicine spending by therapeutic area in 2018 and 2023 (in percentage)
FIG. 27 Upcoming trends in pharmaceutical industry
FIG. 28 FDA drug approval process
FIG. 29 Key milestones of EMA interaction with consumer
FIG. 30 Application for approval or clinical study in China (Step 1)
FIG. 31 Clinical trials in China (Step 2)
FIG. 32 Final approval for drug registration in China (Step 3)
FIG. 33 Final approval for drug registration in China (Step 3)
FIG. 34 Market trends & outlook
FIG. 35 Market driver relevance analysis (Current & future impact)
FIG. 36 R&D spending of top pharmaceutical companies in USD Billion
FIG. 37 Global pharmaceutical R&D spending from 2010 to 2024 in USD Billion
FIG. 38 Artificial intelligence in pharmaceutical industry
FIG. 39 Overview of Pharma 4.0 analytics
FIG. 40 Projected growth of pharmaceutical market in developed and pharmerging markets between 2018 and 2022
FIG. 41 Market restraint analysis
FIG. 42 Market challenge analysis
FIG. 43 Common pharmaceutical supply chain challenges
FIG. 44 Market opportunity analysis
FIG. 45 Number of registered clinical trials from 2000 to 2020
FIG. 46 SWOT analysis, by factor (political & legal economic and technological)
FIG. 47 Porter’s Five Forces Analysis
FIG. 48 Comparison of market entry strategies with their trade-offs
FIG. 49 Components of a market entry solution
FIG. 50 Pharmaceutical manufacturing market: Drug development type outlook and key takeaways
FIG. 51 Pharmaceutical manufacturing market: Drug development type movement analysis
FIG. 52 Advantages of in-house CRO & CMO
FIG. 53 Global in-house pharmaceutical manufacturing market, 2016 - 2027 (USD Billion)
FIG. 54 Challenges overcome by outsourcing
FIG. 55 Outsourced manufacturing activities
FIG. 56 Global outsource pharmaceutical manufacturing market, 2016 - 2027 (USD Billion)
FIG. 57 Pharmaceutical manufacturing market: Formulation outlook and key takeaways
FIG. 58 Pharmaceutical manufacturing market: Formulation movement analysis
FIG. 59 Global pharmaceutical manufacturing market for tablets, 2016 - 2027 (USD Billion)
FIG. 60 Global pharmaceutical manufacturing market for capsules, 2016 - 2027 (USD Billion)
FIG. 61 Global pharmaceutical manufacturing market for injectable, 2016 - 2027 (USD Billion)
FIG. 62 Global pharmaceutical manufacturing market for sprays, 2016 - 2027 (USD Billion)
FIG. 63 Global pharmaceutical manufacturing market for suspensions, 2016 - 2027 (USD Billion)
FIG. 64 Global pharmaceutical manufacturing market for powders, 2016 - 2027 (USD Billion)
FIG. 65 Global pharmaceutical manufacturing market for other formulations, 2016 - 2027 (USD Billion)
FIG. 66 Pharmaceutical manufacturing market: Routes of administration outlook and key takeaways
FIG. 67 Pharmaceutical manufacturing market: Routes of administration movement analysis
FIG. 68 Global pharmaceutical manufacturing market for oral route of administration, 2016 - 2027 (USD Billion)
FIG. 69 Global pharmaceutical manufacturing market for topical route of administration, 2016 - 2027 (USD Billion)
FIG. 70 Global pharmaceutical manufacturing market for parenteral route of administration, 2016 - 2027 (USD Billion)
FIG. 71 Global pharmaceutical manufacturing market for inhalations route of administration, 2016 - 2027 (USD Billion)
FIG. 72 Global pharmaceutical manufacturing market for other route of administration, 2016 - 2027 (USD Billion)
FIG. 73 Pharmaceutical manufacturing market: Therapy area outlook and key takeaways
FIG. 74 Pharmaceutical manufacturing market: Therapy area movement analysis
FIG. 75 Global pharmaceutical manufacturing market for cardiovascular diseases, 2016 - 2027 (USD Billion)
FIG. 76 Global pharmaceutical manufacturing market for pain, 2016 - 2027 (USD Billion)
FIG. 77 Global pharmaceutical manufacturing market for diabetes, 2016 - 2027 (USD Billion)
FIG. 78 Global pharmaceutical manufacturing market for cancer, 2016 - 2027 (USD Billion)
FIG. 79 Global pharmaceutical manufacturing market for respiratory diseases, 2016 - 2027 (USD Billion)
FIG. 80 Global pharmaceutical manufacturing market for other diseases, 2016 - 2027 (USD Billion)
FIG. 81 Pharmaceutical manufacturing market: Prescription outlook and key takeaways
FIG. 82 Pharmaceutical manufacturing market: Prescription movement analysis
FIG. 83 Total prescription drug expenditure in the U.S. from 2009 to 2019 (USD Billion)
FIG. 84 Percent of total health spending that went toward retail prescription drugs, 2010 - 2027
FIG. 85 Out-of-pocket spending on prescription drugs
FIG. 86 Global pharmaceutical manufacturing market for prescription medicines, 2016 - 2027 (USD Billion)
FIG. 87 Global pharmaceutical manufacturing market for OTC medicines, 2016 - 2027 (USD Billion)
FIG. 88 Pharmaceutical manufacturing market: Age Group outlook and key takeaways
FIG. 89 Pharmaceutical manufacturing market: Age Group movement analysis
FIG. 90 Global pharmaceutical manufacturing market children & adolescents, 2016 - 2027 (USD Billion)
FIG. 91 Global pharmaceutical manufacturing market for adults, 2016 - 2027 (USD Billion)
FIG. 92 Number of individuals aged 65 years or over by geographic region in 2019 and 2050
FIG. 93 Global pharmaceutical manufacturing market for geriatric, 2016 - 2027 (USD Billion)
FIG. 94 Pharmaceutical manufacturing market: Distribution channel outlook and key takeaways
FIG. 95 Pharmaceutical manufacturing market: Distribution channel movement analysis
FIG. 96 Global pharmaceutical manufacturing market retail channels, 2016 - 2027 (USD Billion)
FIG. 97 Global pharmaceutical manufacturing market for non-retail, 2016 - 2027 (USD Billion)
FIG. 98 Pharmaceutical manufacturing market: Regional outlook and key takeaways
FIG. 99 Pharmaceutical manufacturing market: Regional movement analysis
FIG. 100 North America
FIG. 101 North America pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 102 The U.S.
FIG. 103 The U.S. pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 104 Canada
FIG. 105 Canada pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 106 Europe
FIG. 107 Europe pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 108 Germany
FIG. 109 Germany pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 110 The U.K.
FIG. 111 The U.K. pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 112 France
FIG. 113 France pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 114 Italy
FIG. 115 Italy pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 116 Spain
FIG. 117 Spain pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 118 Asia Pacific
FIG. 119 Asia Pacific pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 120 Japan
FIG. 121 Japan pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 122 China
FIG. 123 China pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 124 India
FIG. 125 India pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 126 Latin America
FIG. 127 Latin America pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 128 Brazil
FIG. 129 Brazil pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 130 Mexico
FIG. 131 Mexico pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 132 Middle East & Africa
FIG. 133 MEA pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 134 South Africa
FIG. 135 South Africa pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 136 Saudi Arabia
FIG. 137 Saudi Arabia pharmaceutical manufacturing market estimates and forecast, 2016 - 2027 (USD Billion)
FIG. 138 Competition categorization
FIG. 139 Comparison of pharmaceutical sales of top pharma companies, 2019 (In USD Billion)
FIG. 140 Strategy framework
FIG. 141 Market participation categorization

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品製造の世界市場2020-2027:市場規模、シェア、動向分析(Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Drug Development Type, By Formulation, By Route Of Administration, By Therapy Area, By Prescription, By Age Group, And Segment Forecasts, 2020 - 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆